IL6R and ovarian carcinoma: Of 94 patients, 32 (34.0%) showed “high” IL-6R expression, including 14 of 34 serous (41.1%), 3 of 16 mucinous (18.8%), 1 of 11 endometrioid (9.1%), 10 of 20 clear cell (50.0%) and 4 of 13 other (30.8%) ovarian carcinomas.